UroAlert - GU Oncology Daily

June 12, 2026

Videos

Peer-to-Peer Clinical Conversations

Debating First-Line Treatment for BCG-Unresponsive Bladder Cancer - Bogdana Schmidt & Amanda Myers

Bogdana Schmidt

Bogdana Schmidt and Amanda Myers debate first-line therapy for BCG-unresponsive CIS.

Pilot Study Results for NDV-01 Intravesical Therapy in BCG-Unresponsive Bladder Cancer - Boris Chertin

Boris Chertin

Boris Chertin discusses NDV-01.

Beyond the Abstracts

The Changing Landscape of Urinary Diversion Post Cystectomy: A 15-Year Analysis of the NSQIP Database - Beyond the Abstract

Lipid Metabolism of Clear Cell Renal Cell Carcinoma Predicts Survival and Affects Intratumoral CD8 T Cells - Beyond the Abstract

Conference Coverage

ASCO 2026: Adjuvant Nivolumab in High-Risk Muscle-Invasive Urothelial Carcinoma: Real-World Evidence from the SOGUG-NIADY Study of the Spanish Oncology Genitourinary Group (SOGUG)

ASCO 2026: Circulating Tumor DNA (ctDNA) Dynamics as Early Biomarkers of Response to Enfortumab Vedotin plus Pembrolizumab in Advanced Urothelial Carcinoma

ASCO 2026: Patient Experiences with UGN-102 for Recurrent Low Grade Intermediate Risk NMIBC: Insights for Shared Decision Making

AUA 2026: Perspectives of Running Clinical Trials as a Urologist in Community Practice

AUA 2026: ENLIGHTED Phase 3 Trial of Non-Thermal, Drug-Activated Padeliporfin Vascular-Targeted Photodynamic Therapy (VTP) for Low-Grade Upper Tract Urothelial Carcinoma (LG UTUC)

Articles

Editor Selected Abstracts and Commentaries

Bladder Cancer

Blue versus white light for transurethral resection of non-muscle invasive bladder cancer.

A comparative analysis of variant histology and urothelial bladder cancer following radical cystectomy.

Penile & Urethral Cancers

Complications after sentinel node biopsy and inguinal lymph node dissection in penile cancer: a Danish national cohort study.

Renal Cancer

Case Report: donor cell-derived leukemia after allogeneic stem cell transplantation for metastatic renal cell carcinoma.

Clinicopathologic features and survival disparities in early onset clear cell renal cell carcinoma in Texas.

Prostate Cancer

Prostate Imaging Standards for Screening Magnetic Resonance Imaging (PRISM): International Consensus Recommendations.

Effects of androgen receptor signaling inhibitors on absorbed doses in mCRPC patients undergoing [177Lu]Lu-PSMA-617 or [177Lu]Lu-PSMA-I&T therapy: dosimetry results.

Effect of [68Ga]Ga-PSMA-11 PET-CT in the diagnosis of prostate cancer in men with equivocal or clinically high-risk non-suspicious findings on multiparametric MRI (PRIMARY2): a multicentre, non-inferiority, phase 3, randomised controlled trial.

Cell-free DNA in prostate cancer and treatment selection.

Water Vapor Therapy for the Management of Prostate Cancer: The VAPOR 2 Study Initial Results of Ablative Efficacy and Toxicity.

Upper Tract Tumors

Nephroureterectomy for upper tract urothelial carcinoma recurrence in bladder cancer patients treated with radical cystectomy: a multicentric propensity score matched analysis on predictors, practice patterns and survival outcomes.

CONNECT WITH US

Questions or Comments? Email us at editors@urotoday.com

Digital Science Press, LLC
2011 Phaethon Lane,
Reno, NV 89523

You are receiving this email because you have chosen to receive emails from UroToday.

Add us to your address book View this email as a web page Forward to a colleague Manage your subscriptions Unsubscribe

Copyright ©2026 Digital Science Press, LLC